Harris Nesbitt

Harris Nesbitt was the U.S. investment banking arm of BMO Financial Group, providing a comprehensive suite of financial services including M&A advisory, equity research, and capital raising. The firm was particularly noted for its dedicated Healthcare and Life Sciences group, which provided specialized investment banking services to biotechnology, pharmaceutical, and medical technology companies. In 2006, BMO Financial Group retired the Harris Nesbitt brand, consolidating its investment and corporate banking operations under the unified BMO Capital Markets name. During its tenure, the firm was a significant mid-market advisor, helping life science entities navigate public offerings and strategic consolidations.